InvestorsHub Logo
Followers 4053
Posts 151245
Boards Moderated 4
Alias Born 08/05/2009

Re: georgie18 post# 2276

Friday, 06/05/2020 8:13:17 AM

Friday, June 05, 2020 8:13:17 AM

Post# of 2296
the algo's just wont let it rebreak 3.25 again here......BULLS need to push

On June 4, 2020, Tetraphase Pharmaceuticals, Inc. (the “Company”) received notice that the United States Food and Drug Administration (the “FDA”) approved the Company’s supplemental New Drug application (“sNDA”) for a new strength of XERAVATM (eravacycline) for injection for the treatment of complicated intra-abdominal infections in adult patients containing 100mg of eravacycline per vial as well as an extension of the “in-use” shelf life for XERAVA diluted ready for infusion IV solution from 7 days to 10 days under refrigerated conditions for the existing 50 mg/vial product and for the newly approved 100 mg/vial product.


https://ih.advfn.com/stock-market/NASDAQ/tetraphase-pharmaceuticals-TTPH/stock-news/82607977/current-report-filing-8-k


Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals

https://ih.advfn.com/stock-market/NASDAQ/tetraphase-pharmaceuticals-TTPH/stock-news/82601296/melinta-therapeutics-to-acquire-tetraphase-pharmac

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions